Skip to main content
. 2017 Dec 19;17:871. doi: 10.1186/s12885-017-3902-4

Fig. 2.

Fig. 2

Forest plot of the odds ratio of second cancers associated with cisplatin- versus non-cisplatin-based chemotherapy